Chemical Compound

Ginsenoside Rd

CAS Registry Number 68406-27-9
Back to search Request a Quote
Ginsenoside Rd chemical structure
Primary Record

Ginsenoside Rd

In stock
2,713 g
Purity
99.3 %
CAS
68406-27-9

Compound Identifiers & Properties

CAS
68406-27-9
PubChem CID
24721561
SMILES
CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C)O)C)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C
Canonical SMILES
CC(C)=CCC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]1[C@@]3(C)CC[C@H](O)C(C)(C)[C@@H]3[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C[C@]12C

Names & Synonyms

  • Ginsenoside Rd
  • GinsenosideRd
  • 20-O-Glucoginsenoside Rf
  • ginsenoside-Rd
  • gypenoside
  • Gypenosides
  • notoginsenoside N1
  • 20-Glucoginsenoside RF
  • 20-Gluco-ginsenoside-Rf
  • 20-gluco-ginsenoside Rf
  • 20-glc-ginsenoside Rf
  • Ginsenoside 20-Glc-Rf
  • ginsenoside 20-gluco-Rf
  • 20-O-glc-ginsenoside Rf
  • 20-O-glu-ginsenoside Rf
  • RefChem:1064900
  • 20-O-glucosylginsenoside Rf
  • 68406-27-9
  • 20-O-glucosyl-ginsenoside Rf
  • CHEMBL525935
  • DTXSID001314276
  • orb1297137
  • SCHEMBL29380007
  • 20-O-glucopyranosylginsenoside Rf
  • C48H82O19
  • MFCD00799993
  • 52705-93-8
  • DTXCID501744082
  • HY-N8901
  • AKOS040761024
  • ZINC238808898
  • FS-8169
  • 20-beta-D-glucopyranosyl-ginsenoside Rf
  • AC-34660
  • S597
  • SC-46553
  • CS-0149342
  • J1.194.005F
  • 705G938
  • beta-D-Glucopyranoside, (3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-beta-D-glucopyranosyl-
  • (20S)-6alpha-(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyloxy)-20-(beta-D-glucopyranosyloxy)-5alpha-dammara-24-ene-3beta,12beta-diol
  • (2S,3R,4S,5S,6R)-2-((2R,3R,4S,5S,6R)-2-(((6R,10R,12S,14R,17S)-3,12-dihydroxy-4,4,10,14,15-pentamethyl-17-((2S)-6-methyl-2-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxyhept-5-en-2-yl)-1,2,3,5,6,7,8,9,11,12,13,15,16,17-tetradecahydrocyclopenta(a)phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl)oxy-6-(hydroxymethyl)oxane-3,4,5-triol
  • (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-[(1S)-1,5-dimethyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-hex-4-enyl]-3,12-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-3-yl]oxy-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
  • (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
  • (2S,3R,4S,5S,6R)-2-{[(2S)-2-[(1S,3aR,3bR,5S,5aR,7S,9aR,9bR,11R,11aR)-5-{[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-7,11-dihydroxy-3a,3b,6,6,9a-pentamethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-en-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
  • |A-D-Glucopyranoside, (3|A,6|A,12|A)-20-(|A-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-|A-D-glucopyranosyl-
  • 20-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxy-5alpha-dammara-24-ene-6alpha-yl 2-O-(beta-D-glucopyranosyl)-beta-D-glucopyranoside
  • 20-(beta-D-Glucopyranosyloxy)-3beta,12beta-dihydroxydammar-24-en-6alpha-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
  • 6alpha-(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyloxy)-20-(beta-D-glucopyranosyloxy)dammara-24-ene-3beta,12beta-diol
  • beta-D-Glucopyranoside, (3beta,6a,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-beta-D-glucopyranosyl-